{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:56:31Z","timestamp":1792090591896,"version":"4.4.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>End-stage kidney disease (ESKD) and the required kidney replacement therapy (KRT) are significant public health challenges for low-and-middle-income countries. The South African government adopted a KRT rationing policy to balance the growing need for KRT and scarce resources. We aimed to describe the epidemiology and KRT access in patients with ESKD referred to the main public sector hospital in the Free State Province, South Africa.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective study of adult patients with ESKD admitted to Universitas Academic Hospital for KRT, was conducted between 1\u00a0January 2016 and 31 December 2018. A review of the KRT committee decisions to offer or deny KRT based on the KRT rationing policy of the Free State was undertaken. Demographic information, KRT committee outcomes, laboratory test results, and clinical details were collected from assessment tools, KRT committee meeting diaries, and electronic hospital records.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 363 patients with ESKD referred for KRT access, 96 with incomplete records were excluded and 267 were included in the analysis. Median patient age was 40 (interquartile range, 33\u201249) years, and male patients accounted for 56.2\u2009% (150\/267,<jats:italic>p<\/jats:italic>\u2009=\u20090.004) of the cohort. The average annual ESKD incidence was 49.9 (95\u2009% confidence interval [CI], 35.8\u201264.0) per-million-population. The most prevalent comorbidities were hypertension (42.3\u2009%; 113\/267), human immunodeficiency virus (HIV) (28.5\u2009%; 76\/267), and diabetes mellitus (19.1\u2009%; 51\/267). The KRT access rate was 30.7\u2009% (82\/267), with annual KRT incidence rates of 8.05 (95\u2009% CI, 4.98\u201211.1), 11.5 (95\u2009% CI, 7.83\u201215.1), and 14.1 (95\u2009% CI, 10.3\u201218.0) per-million-population in 2016, 2017, and 2018, respectively. Advanced organ dysfunction was the commonest reason recorded for KRT access denial (58.9\u2009%; 109\/185). Age (odds ratio [OR], 1.04; 95\u2009% CI, 1.00\u20121.07;<jats:italic>p<\/jats:italic>\u2009=\u20090.024) and diabetes (OR, 5.04; CI, 1.69\u201215.03;<jats:italic>p<\/jats:italic>\u2009=\u20090.004) were independent predictors for exclusion from KRT, while hypertension (OR, 1.80; 1.06\u20123.04;<jats:italic>p<\/jats:italic>\u2009=\u20090.029) independently predicted advanced organ dysfunction resulting in KRT exclusion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Non-communicable and communicable diseases, including hypertension, diabetes, and HIV, contributed to ESKD, highlighting the need for improved early prevention strategies to address a growing incidence rate. Two-thirds of ESKD patients were unable to access KRT, with age, diabetes mellitus, and advanced organ dysfunction being significant factors adversely affecting KRT access.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12882-021-02387-x","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T06:03:14Z","timestamp":1620712994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["End-stage kidney disease and rationing of kidney replacement therapy in the free state province, South Africa: a retrospective study"],"prefix":"10.1186","volume":"22","author":[{"given":"Thabang T","family":"Molaoa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feziwe B","family":"Bisiwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwazi CZ","family":"Ndlovu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,11]]},"reference":[{"key":"2387_CR1","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","volume":"67","author":"AS Levey","year":"2005","unstructured":"Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2005;67:2089\u2013100.","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"2387_CR2","first-page":"13","volume":"74","author":"S Naicker","year":"2010","unstructured":"Naicker S. Burden of end-stage renal disease in sub-Saharan Africa. Clin Nephrol 2010;74 Suppl 1:13\u20136.","journal-title":"Clin Nephrol"},{"key":"2387_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.7326\/M16-0273","volume":"165","author":"D Murphy","year":"2016","unstructured":"Murphy D, McCulloch CE, Lin F, Banerjee T, Bragg-Gresham JL, Eberhardt MS, et al. Trends in prevalence of chronic kidney disease in the United States. Ann Intern Med. 2016;165:473\u201381.","journal-title":"Ann Intern Med."},{"key":"2387_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1471-2458-8-117","volume":"8","author":"QL Zhang","year":"2008","unstructured":"Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health. 2008;8:117.","journal-title":"BMC Public Health."},{"key":"2387_CR5","doi-asserted-by":"publisher","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","volume":"11","author":"NR Hill","year":"2016","unstructured":"Hill NR, Fatoba ST, Oke JL, Hirst JA, O\u2019Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS One. 2016;11:e0158765.","journal-title":"PLoS One"},{"key":"2387_CR6","doi-asserted-by":"publisher","first-page":"e0205326","DOI":"10.1371\/journal.pone.0205326","volume":"13","author":"NC Hodel","year":"2018","unstructured":"Hodel NC, Hamad A, Praehauser C, Mwangoka G, Kasella IM, Reither K, et al. The epidemiology of chronic kidney disease and the association with non-communicable and communicable disorders in a population of sub-Saharan Africa. PLoS One. 2018; 13:e0205326.","journal-title":"PLoS One"},{"key":"2387_CR7","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1053\/j.ajkd.2007.12.006","volume":"51","author":"FA Arogundade","year":"2008","unstructured":"Arogundade FA, Barsoum RS. CKD prevention in Sub-Saharan Africa: a call for governmental, nongovernmental, and community support. Am J Kidney Dis. 2008; 51:515\u2013523.","journal-title":"Am J Kidney Dis"},{"key":"2387_CR8","doi-asserted-by":"publisher","first-page":"e174-81","DOI":"10.1016\/S2214-109X(14)70002-6","volume":"2","author":"JW Stanifer","year":"2014","unstructured":"Stanifer JW, Jing B, Tolan S, Helmke N, Mukerjee R, Naicker S, et al. The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health. 2014;2:e174-81.","journal-title":"Lancet Glob Health"},{"key":"2387_CR9","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/S0140-6736(09)61087-4","volume":"374","author":"BM Mayosi","year":"2009","unstructured":"Mayosi BM, Flisher AJ, Lalloo UG, Sitas F, Tollman SM, Bradshaw D. The burden of non-communicable diseases in South Africa. Lancet. 2009;374:934\u201347.","journal-title":"Lancet"},{"key":"2387_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/healthcare5030038","volume":"5","author":"H Etheredge","year":"2017","unstructured":"Etheredge H, Fabian J. Challenges in expanding access to dialysis in South Africa\u2014expensive modalities, cost constraints and human rights. Healthcare. 2017;5:38.","journal-title":"Healthcare"},{"key":"2387_CR11","doi-asserted-by":"publisher","first-page":"e0176041","DOI":"10.1371\/journal.pone.0176041","volume":"12","author":"KG Kilonzo","year":"2017","unstructured":"Kilonzo KG, Jones ESW, Okpechi IG, Wearne N, Barday Z, Swanepoel CR, et al. Disparities in dialysis allocation: An audit from the new South Africa. PLoS One. 2017;12:e0176041.","journal-title":"PLoS One"},{"key":"2387_CR12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.semnephrol.2016.05.008","volume":"36","author":"V Wang","year":"2016","unstructured":"Wang V, Vilme H, Maciejewski ML, Boulware LE. The economic burden of chronic kidney disease and end-stage renal disease. Semin Nephrol. 2016;36:319\u201330.","journal-title":"Semin Nephrol"},{"key":"2387_CR13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/kisup.2013.4","volume":"3","author":"S Naicker","year":"2013","unstructured":"Naicker S. End-stage renal disease in Sub-Saharan Africa. Kidney Int Suppl. 2013;3:161\u201363.","journal-title":"Kidney Int Suppl"},{"key":"2387_CR14","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","volume":"385","author":"T Liyanage","year":"2015","unstructured":"Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385:1975\u201382.","journal-title":"Lancet"},{"key":"2387_CR15","doi-asserted-by":"publisher","first-page":"e0228890","DOI":"10.1371\/journal.pone.0228890","volume":"15","author":"M Hassen","year":"2020","unstructured":"Hassen M, Archer E, Pellizzon A, Chikte UME, Davids MR. Human resources for nephrology in South Africa: A mixed-methods study. PLoS One. 2020;15:e0228890.","journal-title":"PLoS One"},{"key":"2387_CR16","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1056\/NEJMsr1405012","volume":"371","author":"BM Mayosi","year":"2014","unstructured":"Mayosi BM, Benatar SR. Health and health care in South Africa\u201320 years after Mandela. N Engl J Med. 2014;371:1344\u201353.","journal-title":"N Engl J Med"},{"key":"2387_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1046\/j.1523-1755.63.s83.25.x","volume":"63","author":"S Naicker","year":"2003","unstructured":"Naicker S. End-stage renal disease in sub-Saharan and South Africa. Kidney Int Suppl. 2003;63:119\u201322.","journal-title":"Kidney Int Suppl"},{"key":"2387_CR18","unstructured":"Statistics SA: Census 2011 Census in brief. Statistics South Africa. 2012. http:\/\/www.statssa.gov.za\/census\/census_2011\/census_products\/Census_2011_Census_in_brief.pdf. Accessed 9 Feb 2021."},{"key":"2387_CR19","unstructured":"Statistics SA: 2016\u20132018 Mid-year population estimates. Statistics South Africa. 2019. http:\/\/www.statssa.gov.za\/. Accessed 5 Feb 2021."},{"key":"2387_CR20","unstructured":"Statistics SA: 2016\u20132018 General Household Survey. Statistics South Africa. 2019. http:\/\/www.statssa.gov.za\/. Accessed 5 Feb 2021."},{"key":"2387_CR21","unstructured":"Moosa MR. Priority setting approach in the selection of patients in the public sector with end-stage kidney failure for renal replacement treatment in the Western Cape Province. 2013. http:\/\/s3.documentcloud.org\/documents\/19489\/moosa-priority-setting-policy-final-feb-24-2010-final.pdf. Accessed on 2nd March 2021"},{"key":"2387_CR22","doi-asserted-by":"crossref","unstructured":"De Meyer V, Abramowicz D, De Meester J, Collart F, Bosmans JL, Cools W, et al. Variability in the incidence of kidney replacement therapy over time in Western industrialised countries: A retrospective registry analysis. PLoS One. 2020;15: e0235004.","DOI":"10.1371\/journal.pone.0235004"},{"key":"2387_CR23","first-page":"3","volume":"1","author":"M Gonzalez-Bedat","year":"2015","unstructured":"Gonzalez-Bedat M, Rosa-Diez G, Pecoits-Filho R, Ferreiro A, Garcia-Garcia G, Cusumano A, et al. Burden of disease: prevalence and incidence of ESRD in Latin America Clin Nephrol. 2015; Suppl 1:3\u20136.","journal-title":"Suppl"},{"key":"2387_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2369-13-33","volume":"13","author":"WA Alashek","year":"2012","unstructured":"Alashek WA, McIntyre CW, Taal MW. Epidemiology and aetiology of dialysis-treated end-stage kidney disease in Libya. BMC Nephrol. 2012;13:33.","journal-title":"BMC Nephrol"},{"key":"2387_CR25","doi-asserted-by":"crossref","unstructured":"Kramer A, Boenink R, Noordzij M, Bosdriesz JR, Stel VS, Beltran P, et al. The ERA-EDTA Registry Annual Report 2017: a summary. Clin Kidney J. 2020;13:693\u2013709.","DOI":"10.1093\/ckj\/sfaa048"},{"key":"2387_CR26","doi-asserted-by":"publisher","first-page":"e0164201","DOI":"10.1371\/journal.pone.0164201","volume":"11","author":"MR Moosa","year":"2016","unstructured":"Moosa MR, Maree JD, Chirehwa MT, Benatar SR. Use of the \u2018accountability for reasonableness\u2019 approach to improve fairness in accessing dialysis in a middle-income country. PLoS One. 2016;11:e0164201.","journal-title":"PLoS One."},{"key":"2387_CR27","unstructured":"Statistics SA. Findings from the Living Conditions Surveys, 2008\/2009\u20132014\/2015. Statistics South Africa. 2017. http:\/\/www.statssa.gov.za\/. Accessed 5 Feb 2021."},{"key":"2387_CR28","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1681\/ASN.V1061281","volume":"10","author":"P Arora","year":"1999","unstructured":"Arora P, Obrador GT, Ruthazer R, Kausz AT, Meyer KB, Jenuleson CS, et al. Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center. J Am Soc Nephrol. 1999;10:1281\u20136.","journal-title":"J Am Soc Nephrol"},{"key":"2387_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2369-9-3","volume":"9","author":"SD Navaneethan","year":"2008","unstructured":"Navaneethan SD, Aloudat S, Singh S. A systematic review of patient and health system characteristics associated with late referral in chronic kidney disease. BMC Nephrol. 2008;9:3.","journal-title":"BMC Nephrol"},{"key":"2387_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.kisu.2017.10.007","volume":"8","author":"M Lunney","year":"2018","unstructured":"Lunney M, Alrukhaimi M, Ashuntantang GE, Bello AK, Bellorin-Font E, Benghanem Gharbi M, et al. Guidelines, policies, and barriers to kidney care: findings from a global survey. Kidney Int Suppl. 2018;8:30\u201340.","journal-title":"Kidney Int Suppl"},{"key":"2387_CR31","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrneph.2017.63","volume":"13","author":"R Vanholder","year":"2017","unstructured":"Vanholder R, Annemans L, Brown E, Gansevoort R, Gout-Zwart JJ, Lameire N, et al. Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrol. 2017;13:393\u2013409.","journal-title":"Nat Rev Nephrol"},{"key":"2387_CR32","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/S0140-6736(09)62004-3","volume":"375","author":"MT James","year":"2010","unstructured":"James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention of chronic kidney disease. Lancet. 2010; 375:1296\u2013309.","journal-title":"Lancet"},{"key":"2387_CR33","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.2215\/CJN.00980207","volume":"2","author":"E Imai","year":"2007","unstructured":"Imai E, Yamagata K, Iseki K, Iso H, Horio M, Mkino H, et al. Kidney disease screening program in Japan: history, outcome, and perspectives. Clin J Am Soc Nephrol. 2007;2:1360\u20136.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2387_CR34","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1440-1797.2006.00587.x","volume":"11","author":"I Codreanu","year":"2006","unstructured":"Codreanu I, Perico N, Sharma SK, Schieppati A, Remuzzi G. Prevention programmes of progressive renal disease in developing nations. Nephrology. 2006;11:321\u20138.","journal-title":"Nephrology"},{"key":"2387_CR35","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ekir.2019.12.003","volume":"5","author":"VA Luyckx","year":"2020","unstructured":"Luyckx VA, Cherney DZI, Bello AK. Preventing CKD in developed countries. Kidney Int Rep. 2020;5:263\u201377.","journal-title":"Kidney Int Rep"},{"key":"2387_CR36","doi-asserted-by":"crossref","unstructured":"Davids MR, Jardine T, Marais N, Jacobs JC, Sebastian S. South African renal registry annual report 2018. Afr J Nephrol. 2020;23:185 \u2013 96.","DOI":"10.21804\/23-1-4458"},{"key":"2387_CR37","doi-asserted-by":"crossref","unstructured":"Saran R, Robinson B, Abbott KC, Bragg-Gresham J, Chen X, Gipson D, et al. US Renal Data System 2019 Annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2020;Suppl 1:6\u20137.","DOI":"10.1053\/j.ajkd.2019.09.003"},{"key":"2387_CR38","unstructured":"International Diabetes Federation. IDF diabetes atlas 8th edition. 2017. https:\/\/www.diabetesatlas.org\/upload\/resources\/previous\/files\/8\/IDF_DA_8e-EN-final.pdf?fbclid=IwAR1dhyFGa3ZlDQngZlEOoDVenpcMPl49ox8Us8nWL9_rSv0-3PIWcZio8bY. Accessed on 2nd March 2021"},{"key":"2387_CR39","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1016\/S0140-6736(10)60550-8","volume":"375","author":"JC Mbanya","year":"2010","unstructured":"Mbanya JC, Motala AA, Sobngwi E, Assah FK, Enoru ST. Diabetes in sub-Saharan Africa. Lancet. 2010;375:2254\u201366.","journal-title":"Lancet"},{"key":"2387_CR40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11892-019-1124-7","volume":"19","author":"C Mapa-Tassou","year":"2019","unstructured":"Mapa-Tassou C, Katte JC, Mba Maadjhou C, Mbanya JC. Economic impact of diabetes in Africa. Curr Diab Rep. 2019;19:5.","journal-title":"Curr Diab Rep"},{"key":"2387_CR41","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41581-018-0001-y","volume":"14","author":"HJ Anders","year":"2018","unstructured":"Anders HJ, Huber TB, Isermann B, Schiffer M. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. Nat Rev Nephrol. 2018;14:361\u201377.","journal-title":"Nat Rev Nephrol"},{"key":"2387_CR42","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ijcard.2017.02.095","volume":"238","author":"L Ma","year":"2017","unstructured":"Ma L, Zhao S. Risk factors for mortality in patients undergoing hemodialysis: A systematic review and meta-analysis. Int J Cardiol. 2017;238:151\u20138.","journal-title":"Int J Cardiol"},{"key":"2387_CR43","doi-asserted-by":"crossref","unstructured":"Chadban SJ, Ahn C, Axelrod DA, Foster BJ, Kasiske BL, Kher V, et al. KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation. Transplantation. 2020;Suppl 1:11\u2013103.","DOI":"10.1097\/TP.0000000000003136"},{"key":"2387_CR44","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1097\/01.tp.0000259621.56861.31","volume":"83","author":"PS Rao","year":"2007","unstructured":"Rao PS, Merion RM, Ashby VB, Port FK, Wolfe RA, Kayler LK. Renal transplantation in elderly patients older than 70 years of age: results from the scientific registry of transplant recipients. Transplantation. 2007;83:1069\u201374.","journal-title":"Transplantation"},{"key":"2387_CR45","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/j.2044-8287.2012.02076.x","volume":"17","author":"K Griva","year":"2012","unstructured":"Griva K, Davenport A, Harrison M, Newman SP. The impact of treatment transitions between dialysis and transplantation on illness cognitions and quality of life\u2013A prospective study. Br J Health Psychol. 2012;17:812\u201327.","journal-title":"Br J Health Psychol"},{"key":"2387_CR46","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1471-2318-13-79","volume":"13","author":"NJ Dempster","year":"2013","unstructured":"Dempster NJ, Ceresa CDL, Aitken E, Kingsmore D. Outcomes following renal transplantation in older people: a retrospective cohort study. BMC Geriatr. 2013;13:79.","journal-title":"BMC Geriatr"},{"key":"2387_CR47","first-page":"iv39-46","volume":"Suppl 4","author":"JM Morales","year":"2012","unstructured":"Morales JM, Marc\u00e9n R, del Castillo D, Andres A, Gonzalez-Molina M, Oppenheimer F, et al. Risk factors for graft loss and mortality after renal transplantation according to recipient age: a prospective multicentre study. Nephrol Dial Transplant. 2012;Suppl 4:iv39-46.","journal-title":"Nephrol Dial Transplant"},{"key":"2387_CR48","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1053\/j.ajkd.2012.08.049","volume":"61","author":"GA Knoll","year":"2013","unstructured":"Knoll GA. Kidney transplantation in the older adult. Am J Kidney Dis. 2013;61:790\u20137.","journal-title":"Am J Kidney Dis."},{"key":"2387_CR49","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12882-017-0466-0","volume":"18","author":"KC Ndlovu","year":"2017","unstructured":"Ndlovu KC, Sibanda W, Assounga A. Peritonitis outcomes in patients with HIV and end-stage renal failure on peritoneal dialysis: a prospective cohort study. BMC Nephrol. 2017; 18:48.","journal-title":"BMC Nephrol"},{"key":"2387_CR50","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3747\/pdi.2016.00165","volume":"37","author":"KCZ Ndlovu","year":"2017","unstructured":"Ndlovu KCZ, Assounga A: Continuous Ambulatory Peritoneal Dialysis in Patients with HIV and End-Stage Renal Failure. Perit Dial Int. 2017; 37:321\u2013330.","journal-title":"Perit Dial Int"},{"key":"2387_CR51","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1097\/01.ASN.0000062963.56513.28","volume":"14","author":"RA Rodriguez","year":"2003","unstructured":"Rodriguez RA, Mendelson M, O\u2019Hare AM, Hsu LC, Schoenfeld P: Determinants of survival among HIV-infected chronic dialysis patients. J Am Soc Nephrol 2003; 14:1307\u201313.","journal-title":"J Am Soc Nephrol"},{"key":"2387_CR52","doi-asserted-by":"publisher","first-page":"e25455","DOI":"10.1002\/jia2.25455","volume":"23","author":"D Havlir","year":"2020","unstructured":"Havlir D, Lockman S, Ayles H, Larmarange J, Chamie G, Gaolathe T et al: What do the Universal Test and Treat trials tell us about the path to HIV epidemic control? J Int AIDS Soc. 2020; 23:e25455.","journal-title":"J Int AIDS Soc"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02387-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-021-02387-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02387-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T23:47:24Z","timestamp":1672098444000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-021-02387-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,11]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2387"],"URL":"https:\/\/doi.org\/10.1186\/s12882-021-02387-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,11]]},"assertion":[{"value":"14 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the University of the Free State Health Sciences Research Ethics Committee (UFSHSD2019\/1083), and research was conducted in accordance with the principles of the Declaration of Helsinki. Informed consent from the participants was not required owing to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"174"}}